Listed by the USPTO as CROW, ROBERT THOMAS
Tech Center 4100 • Art Units: 1634 1656 1677 1681 1682 1683 1699 1798 4100 4144
This examiner grants 42% of resolved cases
CROW, ROBERT THOMAS is assigned to USPTO Technology Center 4100 and art unit 1634. His profile covers 722 resolved cases, with a 41.6% allowance rate and a 32.5% interview lift. The median time to allowance is 1452 days. The lower allowance outcome and positive interview association make early interview preparation, clear claim differentiation, and disciplined response strategy important considerations.
The principal companies are Illumina Inc., Oxford Nanopore Technologies PLC, and 10x Genomics Inc. The leading firms are WOLF GREENFIELD & SACKS, P.C., MEDLER FERRO WOODHOUSE & MILLS PLLC, and BROWN RUDNICK LLP. These names identify the principal life sciences applicants and counsel in the record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18423678 | HYBRIDIZATION COMPOSITIONS AND METHODS USING FORMAMIDE | Non-Final OA | Agilent Technologies, Inc. |
| 18889917 | METHOD FOR NANOPORE RNA CHARACTERISATION | Non-Final OA | Oxford Nanopore Technologies PLC |
| 18160816 | METHOD | Non-Final OA | Oxford Nanopore Technologies PLC |
| 18065735 | ENZYME STALLING METHOD | Final Rejection | Oxford Nanopore Technologies PLC |
| 18585357 | FLUID DELIVERY METHODS | Non-Final OA | 10x Genomics, Inc. |
| 18542038 | METHODS AND COMPOSITIONS FOR ASSESSING PERFORMANCE | Non-Final OA | 10x Genomics, Inc. |
| 18698128 | NUCLEIC ACID HYBRIDIZATION CASCADE ENHANCED BY DROPLET EVAPORATION | Non-Final OA | University of Rochester |
| 18027978 | SAMPLE PROCESSING DEVICE, SAMPLE PROCESSING APPARATUS, AND SAMPLE PROCESSING METHOD | Final Rejection | Hitachi High-Tech Corporation |
| 17783750 | COMPOSITIONS AND METHODS FOR LIGHT-DIRECTED BIOMOLECULAR BARCODING | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17631167 | METHODS AND COMPOSITIONS RELATED TO TARGET ANALYSIS | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 18420048 | CONCENTRATING A TARGET MOLECULE FOR SENSING BY A NANOPORE | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 18348235 | TRANSLOCATION CONTROL FOR SENSING BY A NANOPORE | Final Rejection | Roche Sequencing Solutions, Inc. |
| 18021248 | LIQUID CRYSTAL BIOSENSOR WITH ULTRAHIGH SENSITIVITY AND SELECTIVITY | Final Rejection | Purdue Research Foundation |
| 17769536 | METHODS FOR MULTI-FOCAL IMAGING FOR MOLECULAR PROFILING | Non-Final OA | Children's Medical Center Corporation |
| 18618263 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID SEQUENCING | Non-Final OA | Illumina, Inc. |
| 18389877 | MULTI-SURFACE BIOLOGICAL SAMPLE IMAGING SYSTEM AND METHOD | Non-Final OA | ILLUMINA, INC. |
| 18467770 | NANOPARTICLE WITH POLYNUCLEOTIDE BINDING SITE AND METHOD OF MAKING THEREOF | Non-Final OA | ILLUMINA, INC |
| 18343696 | SEQUENCING NANOPARTICLES AND METHODS OF MAKING THE SAME | Final Rejection | ILLUMINA, INC. |
| 18176761 | FUNCTIONALIZED NANOSTRUCTURES AND FLOW CELL DEPRESSIONS | Final Rejection | ILLUMINA, INC. |
| 18164341 | Microfluidic Droplet Generators | Non-Final OA | ILLUMINA, INC. |
| 18533836 | METHOD FOR ISOLATING NUCLEIC ACIDS FROM A FORMALDEHYDE RELEASER STABILIZED SAMPLE | Final Rejection | QIAGEN GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy41.6% of resolved applications examined by Robert Thomas Crow were allowed (722 resolved cases), compared with 30.4% across Art Unit 1634 over the last five years.
This examiner's interview lift is +32.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Robert Thomas Crow took 1,452 days on average from filing to allowance.
Robert Thomas Crow examines applications in Art Unit 1634 in Tech Center 4100.
